US Patent 12083169 Alkaline phosphatase polypeptides and methods of use thereof
Patent 12083169 was granted and assigned to Alexion Pharmaceuticals on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+71 properties)
Article (+353 characters)
US Patent 12083169 Alkaline phosphatase polypeptides and methods of use thereof
Article
Patent abstract
Featured are pharmaceutical compositions that include a soluble alkaline phosphatase for treating bone mineralization disorders, such as hypophosphatasia (HPP), and symptoms thereof. The polypeptides include a soluble alkaline phosphatase (sALP) or fragment thereof, which is derived from a naturally occurring alkaline phosphatase (ALP).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Eric Falcone0
Jonathan Monteleone0
Tatyana Mezhebovsky0
Walter C. Voegtli0
Yang Guo0
Yuhong Wu0
Date of Patent
September 10, 2024
0Patent Application Number
176692750
Date Filed
February 10, 2022
0Patent Citations
0
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12083169 Alkaline phosphatase polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
